CLINICAL TRIALS IN EL PASO: ADVANCING MEDICAL RESEARCH ACROSS DIVERSE HEALTH CONDITIONS
El Paso is up-and-coming in medical research, with various clinical trials to improve treatments and outcomes for numerous health conditions. Below is a comprehensive overview of ongoing clinical trials in El Paso, categorized by disease indication. Each group includes a general description of the studies' aim and a list of specific trials.
ASTHMA AND ALLERGY STUDIES
Aim: To evaluate new treatments for asthma and allergies to improve patient outcomes and quality of life.
- A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines - Western Sky Medical Research 
- A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) - El Paso Pulmonary Association 
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations 
- An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib - Western Sky Medical Research 
- Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy 
- Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts - Western Sky Medical Research 
- Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma (AIRCULES) - Western Sky Medical Research 
CLINICAL EDUCATION
Aim: Provide Education to Patients and Professionals to better inform choices in healthcare.
- Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention - University of Texas at El Paso 
- Culturally Tailored HPV Psychoeducational Multimedia Intervention - University of Texas at El Paso 
- Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas - University of Texas at El Paso 
- VIGOR: Virtual Genome Center for Infant Health - The Hospitals of Providence 
DEPRESSION
Aim: To develop treatments to manage depression.
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) - Texas Tech University Health Sciences Center at El Paso 
DERMATOLOGY
Aim: These trials focus on developing and improving treatments for various dermatological conditions, enhancing skin health and patient comfort.
- A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) - 3A Research 
- An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib - Western Sky Medical Research 
- A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (TARGET-DERM) - El Paso Dermatology Center 
DEVICES AND DIAGNOSTICS
Aim: To develop and/or improve means of assessing, diagnosing, determining, monitoring, and treating conditions and diseases.
- Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy (PAS) - Texas Procedure Center 
- Hydrus® Microstent New Enrollment Post-Approval Study (CONFIRM) - El Paso Eye Surgeons P.A. 
- Patient-Centered Reproductive Decision Support Tool for Women Veterans (MyPath) - El Paso VA Healthcare System 
- AngelMed Guardian® System PMA Post Approval Study - Texas Cardiovascular Institute 
- Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon (NaviAid2) - Texas Tech Health Sciences Center at El Paso 
- A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery (ACCESS2) - Arteries & Veins 
- IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery - The Hospitals of Providence 
- Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy - Spine & Rehab Specialists 
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study - El Paso Center for GI; El Paso Specialty Hospital, Sierra Medical Center; Gateway Surgical Center 
- Surveillance AFter Extremity Tumor surgerY (SAFETY) - Texas Tech Health Sciences Center at El Paso 
EPILEPSY, MIGRAINE AND HEADACHES
Aim: To assess new therapies and their effectiveness in reducing the frequency and severity of seizures, migraines and headaches in both children and adults; To test the effectiveness of new medications for controlling seizures in individuals with epilepsy.
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine (Kaleidoscope) - 3A Research 
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) - 3A Research 
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment - ANESC/ANRC 
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine - ANESC/ANRC 
- Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? - Texas Tech University Health Sciences Center of El Paso 
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 3) - ANESC/ANRC 
- Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI - William Beauomont Army Medical Center 
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2) - El Paso Medical Research Institute 
- Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures - ANESC/ANRC 
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS) El Paso Medical Research Institute 
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE2) - ANESC/ANRC 
- Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One (MEDO) - Texas Tech Health Sciences Center at El Paso 
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 3) - ANESC 
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE2) - ANESC 
- Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures - ANRC 
- Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) - Texas Tech Health Sciences Center at El Paso 
HYPOTHYROIDISM
Aim: To compare the safety and efficacy of different thyroid hormone replacement therapies.
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants - Academy of Diabetes, Thyroid and Endocrine 
CARDIOVASCULAR AND METABOLIC DISORDERS
Aim: To explore novel treatments and interventions for cardiovascular diseases and associated conditions.
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (REDEFINE 3) - Academy of Diabetes, Thyroid and Endocrine 
- A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting - Academy of Diabetes, Thyroid and Endocrine 
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS) - Academy of Diabetes, Thyroid and Endocrine 
- A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients - David Turbay, MD 
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES) - David Turbay, MD 
- A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen - David Turbay, MD 
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation (ATHENA) - David Turbay, MD 
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES) - El Paso Medical Research Institute 
- Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy (PAS) - Texas Procedure Center 
- Edoxaban for IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) (ENRICH-AF) - Texas Tech University Health Sciences Center of El Paso 
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) - Texas Tech University Health Sciences of El Paso 
- 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels - 3A Research 
- Endovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW) - Texas Tech University Health Sciences Center at El Paso 
- Sleeve Gastrectomy Outcomes With Different Stapling Devices - William Beaumont Army Medical Center 
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES) - El Paso Medical Research Institute 
- A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE) - DaVita Clinical Research 
- A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL) (DEEPER REVEAL) - El Paso Cardiology Associates 
- IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact (IMPROVE) - Texas Tech Health Sciences Center at El Paso 
CANCER
Aim: To explore new treatments to combat the progression of cancer.
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63) - Texas Oncology 
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63) - Texas Oncology 
- A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) - Texas Oncology 
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) - Texas Oncology 
- A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) - Texas Oncology; El Paso Cancer Treatment Center 
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy (INAVO121) - Texas Tech University Health Sciences Center of El Paso 
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4) - William Beauomont Army Medical Center 
- Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) (VIKTORIA-1) - William Beaumont Army Medical Center 
- A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 - Dr. Haroutioun S. Shahinian, MD 
- A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors - Dr. Haroutioun S. Shahinian, MD 
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) - Dr. Haroutioun S. Shahinian, MD 
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63) - Texas Oncology 
- A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs - Renovatio Clinical 
- Study of INKmune in Patients With mCRPC (CaRe Prostate) (CaRe) - Renovatio Clinical 
ALZHEIMER'S DISEASE
Aim: To explore preventive treatments and assess the progression and management of Alzheimer's disease.
- A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3) - ANRC 
- Study to Assess Adverse Events, Change in Disease Activity, and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease (Abroad) - ANESC 
- Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type 
GASTROENTEROLOGY
Aim: Investigate treatments for various gastrointestinal conditions, enhancing digestive health and patient outcomes.
- A Study to Assess the Safety and Efficacy of SER-301 in Adults With Mild-to-Moderate Ulcerative Colitis 
- A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis - Texas Gastro Research 
- Study to Evaluate the Efficacy and Safety of Mirikizumab in Pediatric Participants With Moderate-to-Severe Ulcerative Colitis 
- A Study to Evaluate the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease 
- Study of Efficacy, Safety, and Tolerability of Oral Upadacitinib in Pediatric Participants With Moderate to Severe Ulcerative Colitis 
- Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms (PSAGS) - Texas Tech Health Sciences Center at El Paso 
- GpCRC Pediatric Gastroparesis Registry 2 (PGpR2) - Texas Tech Health Sciences Center at El Paso 
- Gastroparesis Registry 4 (GpR4) - Texas Tech Health Sciences Center at El Paso 
- Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis (GES+PP) - Texas Tech Health Sciences Center at El Paso 
- ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk - Texas Gastro Clinic 
- Multi-analyte Blood Test Clinical Trial (LIVER-1) - Texas Gastro Research LLC 
- A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) (NATiV3) - Gastro Clinic 
- Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis (PALEKONA) - Gastroenterology Research of America 
- Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis - Great Lakes Research Institute 
- Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices (LOVARB) - Texas Tech University Health Sciences Center 
- PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study - Harmony United Research 
KIDNEY DISEASES
Aim: To investigate treatments for various kidney conditions, focusing on efficacy and patient outcomes.
- Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease (AMPLITUDE) - DaVita Clinical Research 
- A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis - DaVita Clinical Research 
- A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis - El Paso Medical Research Institute 
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY) 
- A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE) - DaVita Clinical Research 
- Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease (MIRO-CKD) - El Paso Kidney Consultants 
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function (BalanceD-HF) - El Paso Kidney Consultants 
- A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis - El Paso Medical Research Institute 
PULMONARY AND RESPIRATORY
Aim: To improve the treatment of various pulmonary and respiratory conditions.
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1) - Texas Tech University Health Sciences Center at El Paso 
- Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms? - University Medical Center 
- Cromolyn Sodium for Treatment of COVID-19 Pneumonia - Texas Tech Health Sciences Center at El Paso 
- A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - El Paso Pulmonary Association 
- Screening for High Frequency Malignant Disease (SHIELD) - El Paso Pulmonary Association 
- Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis - El Paso Pulmonary Association 
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF (LEVEL) - Texas Tech Physicians of El Paso 
- A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection - El Paso Pulmonary Association 
- A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to < 24 Months - Texas Tech University Health Sciences at El Paso 
PEDIATRIC AND ADOLESCENT ONCOLOGY
Aim: To improve the understanding and treatment of various pediatric and adolescent cancers.
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study - El Paso Children’s Hospital 
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - El Paso Children’s Hospital 
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT - El Paso Children’s Hospital 
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma - El Paso Children’s Hospital 
- Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy - El Paso Children’s Hospital 
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia - El Paso Children’s Hospital 
- A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - El Paso Children’s Hospital 
- Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia - El Paso Children’s Hospital 
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) - El Paso Children’s Hospital 
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab - El Paso Children’s Hospital 
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors - El Paso Children’s Hospital 
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia - El Paso Children’s Hospital 
- A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for Primary Central Nervous System Tumors - El Paso Children’s Hospital 
- B Acute Lymphoblastic Leukemia - El Paso Children’s Hospital 
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis - El Paso Children’s Hospital 
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma - El Paso Children’s Hospital 
- Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma - El Paso Children’s Hospital 
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma - El Paso Children’s Hospital 
- **Project: Every Child for Younger Patients - El Paso Children’s Hospital 
PEDIATRIC
Aim: Improve the treatment of hospitalized pediatric patients.
- Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis - El Paso Children’s Hospital 
- HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis (SEPSIS-SHIELD) - Texas Tech Health Sciences Center at El Paso 
OPHTHALMOLOGY
Aim: Improve methods for corrective surgeries and treatments of the eyes.
- Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma - El Paso Eye Surgeons P.A. 
- Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma - El Paso Eye Surgeons P.A. 
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) - El Paso Eye Surgeons P.A. 
KNEE OSTEOARTHRITIS
Aim: To improve the quality of life of those with Osteoarthritis of the Knee.
- Upper and Lower Extremity Exercise and Exercise-Induced Hypoalgesia in Knee Osteoarthritis - University of Texas at El Paso 
- Effects of Vagus Nerve Stimulation on Central Pain Sensitivity & Parasympathetic Function in Knee Osteoarthritis - University of Texas at El Paso 
RHEUMATOID ARTHRITIS AND INFLAMMATION
Aim: To improve treatments for inflammatory diseases.
- A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH) - El Paso Integrated Physicians Group P.A. 
- A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis (SPECIFI-RA) - Texas Arthritis Center 
- RA-PRO PRAGMATIC TRIAL (RA-PROPR) - Texas Arthritis Center 
- A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2) - Texas Arthritis Center 
- Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) (BRAVIO) - Texas Tech Health Sciences Center at El Paso 
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus (ALLEGORY) - Texas Arthritis Center 
For further information on Clinical Trials, go to https://clinicaltrials.gov and enter El Paso, TX in the location option.
